Clinical Guidelines

Practice Management for Photobiomodulation of the Retina

Share

8 Key Takeaways
  • 1

    PBM is FDA-approved for treating intermediate dry AMD.

  • 2

    Administered in clinics, not surgical settings.

  • 3

    Understanding healthcare worker regulations is crucial for PBM delivery.

  • 4

    CPT code 0936T applies for reimbursement.

  • 5

    Compliance with state laws affects practice scope.

  • 6

    Medicare claims for PBM may vary by region.

  • 7

    Ensure proper patient consent and documentation.

  • 8

    Educational resources available for coding and billing complexities.

Original Source(s)

Related Content